References
-
1.
Alavi SM, Behdad F. Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):101-4. [PubMed ID: 22312381].
-
2.
Amin-Esmaeili M, Rahimi-Movaghar A, Razaghi EM, Baghestani AR, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2012;12(1):23-31. [PubMed ID: 22451840]. https://doi.org/10.5812/kowsar.1735143X.806.
-
3.
Kassaian N, Adibi P, Kafashaian A, Yaran M, Nokhodian Z, Shoaei P, et al. Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran. Int J Prev Med. 2012;3(Suppl 1):S156-61. [PubMed ID: 22826759].
-
4.
Kheirandish P, Seyedalinaghi SA, Hosseini M, Jahani MR, Shirzad H, Foroughi M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr. 2010;53(2):273-5. [PubMed ID: 20104123]. https://doi.org/10.1097/QAI.0b013e3181be6dde.
-
5.
Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, et al. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med. 2010;13(4):318-23. [PubMed ID: 20597566].
-
6.
Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy. 2007;18(5):359-63. [PubMed ID: 17854723]. https://doi.org/10.1016/j.drugpo.2007.02.007.
-
7.
Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004;81(1):20-4. [PubMed ID: 15047780]. https://doi.org/10.1093/jurban/jth084.
-
8.
Nataparan C. 2000. Methadone maintenance and harm reduction in northern Thailand. Available from: http://www.drugtext.org/Opiates-heroin-methadone/methadone-maintenance-and-harm-reduction-in-northern-thailand.html.
-
9.
Chandrasena R. Management of opium dependence in a general hospital psychiatry unit. Br J Addict. 1980;75(2):163-7. [PubMed ID: 6930293].
-
10.
Somogyi AA, Larsen M, Abadi RM, Jittiwutikarn J, Ali R, White JM. Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol. 2008;66(5):640-7. [PubMed ID: 19032172]. https://doi.org/10.1111/j.1365-2125.2008.03277.x.
-
11.
Auriacombe M, Grabot D, Daulouede JP, Vergnolle JP, O'Brien C, Tignol J. A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status. J Subst Abuse Treat. 1994;11(6):565-8. [PubMed ID: 7884840].
-
12.
Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med. 2002;5(3):184-90.
-
13.
2011. United nations office on drug and crime. World drug report. Available from: http://www.unodc.org/unodc/en/data-and-analysis/WDR-2011.html.
-
14.
Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Beckley Foundation Drug Policy Programme, Briefing Paper. 2005;8.
-
15.
Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet. 2006;368(9534):434-5. [PubMed ID: 16890814]. https://doi.org/10.1016/S0140-6736(06)69132-0.
-
16.
Zamani S, Vazirian M, Nassirimanesh B, Razzaghi EM, Ono-Kihara M, Mortazavi Ravari S, et al. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2010;14(4):885-90. [PubMed ID: 18483849]. https://doi.org/10.1007/s10461-008-9404-2.
-
17.
2011. Analysis of the world situation. Available from: http://www.incb.org/documents/Publications/AnnualReports/AR2011/AR_2011_E_Chapter_III.pdf.
-
18.
Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction. 2008;103(9):1484-92. [PubMed ID: 18636999]. https://doi.org/10.1111/j.1360-0443.2008.02249.x.
-
19.
Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007;102(9):1472-82. [PubMed ID: 17645427]. https://doi.org/10.1111/j.1360-0443.2007.01914.x.
-
20.
Zarghami M. Is methadone substitution the best treatment of choice for opioid dependence? Iran J Psychiatry Behav Sci. 2008;2(2):1-4.